Overslaan en naar de inhoud gaan
Home
language-selector-globe Belgium | nl
Choose Location
language-selector-globe Belgium |
DutchFrançais
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe be
Choose Location
language-selector-globeBelgium
DutchFrançais
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • Over 
      • Novartis in België 
        • Onze directie in België 
      • Innovatieve geneesmiddelen 
      • Diversiteit & Inclusie 
      • Mensen & Cultuur 
      • Contact 
      girl with a flower Over
    • Patienten en zorgverleners 
      • Novartis inzet voor patiënten en zorgverleners 
      • Transparantie 
      • Toegang tot zorg 
      • Subsidie aanvragen 
      • Melden van bijwerkingen 
      couple holding hands Patienten en zorgverleners
    • Zorgverleners 
      • Zorgverlenerportaal 
      • Therapeutische gebieden 
      • Onze producten 
      • Novartis pijplijn 
      • Klinische proeven van Novartis 
      • Bijwerking melden 
      Deux femmes médecins Zorgverleners
    • Onze impact 
      • Duurzaamheid 
      • Onze impact in België 
      • Onze inzet 
      • Onze ethische gedragscode 
      • Ethiek, risico en naleving 
      Trees in a forest Ons ESG-engagement
    • Nieuws 
      • Persberichten 
      • Nieuws 
      • Perscontact 
      photo of people in a meeting hall Nieuws
    • Jobs 
      • Jobs bij Novartis België 
      • Openstaande vacatures bij Novartis 
      • Locaties 
        • Werken voor Novartis in Puurs 
        • Werken voor Novartis in Vilvoorde 
      • Ontmoet onze teams 
        • Werken in Supply Chain 
        • Werken in Manufacturing 
        • Werken in Quality 
        • Werken als Young Graduate 
        • Werken in Business Services 
        • Werken in Sales & Marketing 
        • Werken in Medical Science 
        • Werken in Market Access 
      • Novartis als wereldspeler 
      • Welzijn 
      join us hero image Jobs
    un scientifique écrit sur un mur de verre Home
  1. Home
  2. Jobs
  3. Openstaande vacatures bij Novartis
  • Sort by Sort ascending
  • Functie titel Aflopend sorteren
  • Site
  • Plaats
  • Afdeling
  • Bedrijf
  • Functional Area
  • Datum geplaatst
Functie titel Aflopend sorteren Site Plaats Afdeling Bedrijf Functional Area Datum geplaatst
Japan Program Clinical Head (IMM) Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Innovative Medicines Research & Development 10 September 2024
Japan Program Head (Immunology) Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development 16 Oktober 2024
Japan Program Head (Neuroscience & GTx) Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development 16 Oktober 2024
Japan Program Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development 10 Juli 2024
Laboratory Equipment Operations Specialist (80-100%*) Basel (City) Switzerland Biomedical Research Pharma Research Research & Development 02 Oktober 2024
Lead Principal CDS Specialist Mumbai (Office) India Development Innovative Medicines Research & Development 15 September 2024
Lead, Medical Excellence Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development 02 Juli 2024
Lead, RWE and Evidence Excellence Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development 10 Juli 2024
Manager - Strategy and Operations Hyderabad (Office) India Development Innovative Medicines Research & Development 03 Oktober 2024
Manager Regulatory Affairs Process Excellence London (The Westworks) United Kingdom Development Innovative Medicines Research & Development 02 September 2024
Manager Regulatory Policy & Intelligence London (The Westworks) United Kingdom Development Innovative Medicines Research & Development 02 September 2024
Manager, Clinical Disclosure Office Barcelona Gran Vía Spain Development Innovative Medicines Research & Development 20 Juni 2024
Manager, Reg&Dev Policy Japan​ Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development 12 September 2024
Manager, TRD Project management Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development 16 Oktober 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development 15 Juli 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development 11 September 2024
Medical Advisor In Market Brands Vilvoorde Belgium International Innovative Medicines Research & Development 03 Oktober 2024
Medical Advisor, HEMA Shanghai (Shanghai) China International Innovative Medicines Research & Development 18 Oktober 2024
Medical Advisor, Ophtha Shanghai (Shanghai) China International Innovative Medicines Research & Development 18 Oktober 2024
Medical Affairs Lead (m/w/d), Solid Tumors Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development 06 September 2024
Medical Affairs Lead Specialty Warsaw Poland International Innovative Medicines Research & Development 11 Oktober 2024
Medical Content Lead (m/w/d), Hematology Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development 09 September 2024
Medical Education Manager, Breast Cancer Montreal Canada International Innovative Medicines Research & Development 18 Oktober 2024
Medical Field Trainer Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development 29 Augustus 2024
Medical Head Oncology Milano Italy International Innovative Medicines Research & Development 14 Oktober 2024
Medical Head Radioligand Therapy Rueil-Malmaison France International Innovative Medicines Research & Development 02 Juni 2024
Medical Lead Copenhagen Denmark International Innovative Medicines Research & Development 14 Oktober 2024
Medical Lead Oncology Mumbai (Head Office) India International Innovative Medicines Research & Development 16 September 2024
Medical Safety and Processes Manager Barcelona Gran Vía Spain Development Innovative Medicines Research & Development 18 Oktober 2024
Medical Safety Lead Hyderabad (Office) India Development Innovative Medicines Research & Development 10 Oktober 2024
Medical Science Liaison West Bengal India International Innovative Medicines Research & Development 02 September 2024
Medical Science Liaison Guangzhou (Guangdong Province) China International Innovative Medicines Research & Development 08 Augustus 2024
Medical Science Liaison - Solid Tumors Bucuresti Romania International Innovative Medicines Research & Development 17 Oktober 2024
Medical Science Liaison (MSL) Neuroscience Eastern PA, Northern NJ Field Non-Sales (USA) USA US Innovative Medicines Research & Development 17 Oktober 2024
Medical Science Liaison (MSL) ONC Solid Tumor Chicago Territory Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development 17 Oktober 2024
Medical Science Liaison (MSL), Czech Republic Prague Czech Republic International Innovative Medicines Research & Development 27 September 2024
Medical Science Liaison Allergy / Derm MN, WI, ND, SD Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development 25 April 2024
Medical Science Liaison Hemato (Siberia) Novosibirsk Russian Fed. International Innovative Medicines Research & Development 20 September 2024
Medical Science Liaison Immunology Field Force (England / Wales) United Kingdom International Innovative Medicines Research & Development 10 Oktober 2024
Medical Science Liaison Lead Warsaw Poland International Innovative Medicines Research & Development 18 April 2024
Medical Science Liaison Neuro Ekaterinburg Russian Fed. International Innovative Medicines Research & Development 25 Juli 2024
Medical Science Liaison Onc Prostate Radioligand Therapies DFW or North Remote USA US Innovative Medicines Research & Development 05 Juni 2024
Medical Science Liaison Onc Prostate Radioligand Therapies Michigan Territory Field Non-Sales (USA) USA US Innovative Medicines Research & Development 09 Oktober 2024
Medical Science Liaison, Immunology Chongqing (Chongqing Province) China International Innovative Medicines Research & Development 30 September 2024
Medical Scientific Liaison İstanbul Kavacık Turkey International Innovative Medicines Research & Development 26 September 2024
Medical Scientific Liaison Manager, Immunologie (w/m/d), Gebiet: Sachsen Saxony (with Corpus Christi) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development 18 Oktober 2024
MSL Manager - Hematology Shanghai (Shanghai) China International Innovative Medicines Research & Development 14 Mei 2024
MSL Manager, RLT Shanghai (Shanghai) China International Innovative Medicines Research & Development 18 April 2024
MSL Tumeurs Solides - Nord Est Field Non-Sales (France) France International Innovative Medicines Research & Development 29 April 2024
NS Therapeutic Area Biomarker Lead (Associate Director) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development 11 Oktober 2024

Paginering

  • ‹ Vorige pagina
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • › Volgende pagina

Novartis België

Direct naar
  • Over Novartis
  • Bijwerking melden
  • Werken bij Novartis
  • Onze impact
  • Contact
Mediacentrum
  • Mediacontacten
  • Persberichten
  • Nieuws
Ons portfolio
  • Innovatie
  • Medicijnen
Andere websites van Novartis
  • Zorgverlenersportaal
  • Novartis Global
Onder footer
© 2024 Novartis AG
  • Privacybeleid
  • Gebruiksvoorwaarden
  • Toegankelijkheid
  • Algemene inkoop voorwaarden
  • Cookie-instellingen
  • Sitemap
Novartis Site Directory
Deze website is bestemd voor inwoners van België